Mitchell Center banner

Mitchell Center Team


Primary Faculty Mitchell Center

  • Taglialatela, Giulio, PhD

    Giulio Taglialatela, PhDProfessor & Mitchell Center Director

    The existence of individuals who remain cognitively intact despite the presence of neuropathology normally associated with fully symptomatic Alzheimer’s Disease (AD), also called resilient, suggests that there is an intrinsic way for the human brain to resist (or significantly delay) the events that lead to cognitive impairment in AD. Understanding the involved cellular mechanism(s) would thus reveal a very effective target to develop a novel therapeutic concept centered on inducing cognitive resistance in affected patients. With this ultimate goal in mind, the main research focus of Dr. Taglialatela’s group is to determine the molecular basis of brain/cognitive resilience in the face of AD pathology and to explore approaches to induce such resistance in anyone affected by the disease. Dr. Taglialatela’s group uses autoptic human brains, transgenic animal models and in vitro neuronal systems to interrogate basic molecular mechanisms of synaptic/neuronal resilience and focus on calcineurin inhibitors, neural stem cell derived exosomes (and their miRNA content) and near-infrared light as viable approaches to elicit it.

    BioCurriculum Vitae , Lab Page

  • Dineley, Kelly, PhD

    Kelly Dineley, PhDProfessor

    The overall goal of Dr. Dineley`s research program is to better understand the maladaptive neuroplastic changes in the brain related to cognitive deficits that arise in neurological disorders such as Alzheimer’s disease. For the past 15 years, she has been studying neuroplasticity in animal models of neurological and psychiatric disorders, including infectious disease, Alzheimer’s and Parkinson’s disease. Dr. Dineley has expertise in the design and study of rodent behavioral models for a variety of disease states with special emphasis on quantitative measures of cognitive and motor deficits in addition to the application of pharmacological tools and genetic manipulations to test mechanistic hypotheses. She is a member of the academy for master teachers and Director of the Rodent In Vivo Assessment (RIVA) Core.

    BioCurriculum Vitae 

  • Fang, Xiang, MD, PhD

    Xiang Fang, MD, PhDAssociate Professor

    Dr. Fang has extensive research experience in the fields of neurodegenerative diseases, neuroimmunology, lipid metabolism, inflammation, and reactive oxygen species (ROS). His current research focus on 1) The role of neuroprotective indoles in delaying the onset of cognitive decline; 2) Molecular mechanisms, biomarkers, and therapeutic approach for Myasthesnia Gravis (MG); 3) tRNA-derived RNA Fragments and Alzheimer’s disease; 4) Targeting soluble epoxide hydrolase as a novel therapeutic approach for HIV-related pain. His group also is interested in alcohol-induced mitochondrial dysfunction and role of endogenous cannabinoids in neurodegenerative diseases.

    BioCurriculum Vitae

  • Kayed, Rakez, PhD

    Rakez Kayed, PhDProfessor

    Dr. Kayed’s area of research focuses on the mechanisms of protein misfolding and aggregation, as well as the toxicity of proteinaceous deposits in neurodegenerative disorders, mainly Alzheimer’s disease, Parkinson’s disease, tauopathies and amyloidosis. His lab also studies the polymorphism of amyloid and tau species in tauopathies and traumatic brain injury and the development of therapeutic monoclonal antibodies toxic oligomeric amyloids.

    BioCurriculum Vitae 

  • Krishnan, Balaji, PhD

    Balaji Krishnan, PhDAssistant Professor

    Dr. Krishnan lab is interested in the basic mechanism associated with synaptic neurotransmission in central and peripheral nervous systems. His group utilizes electrophysiological, behavioral and biochemical approaches using different vertebrate and invertebrate animal models to investigate mechanisms underlying synaptic dysfunction. Currently, Dr Krishnan’s lab has interesting observations associated with neurodegenerative disorders, neuropsychiatric condition and effects of radiation in long-term space flights such as those to Mars. His group is interested in basic mechanisms and preclinical therapeutic strategies with emerging interests in biomarkers for assessments of the neurological states.

    BioCurriculum Vitae , Lab Page

  • Limon, Agenor, MSc, PhD

    Agenor Limon, MSc, PhDAssistant Professor

    Dr Limon area of research is focused on elucidating the physiological and pathophysiological processes that underlie synaptic and extrasynaptic remodeling of inhibitory and excitatory signaling in neurological disorders, and how they determine the global excitatory to inhibitory synaptic balance (E/I ratio) that determines the electrical brain activity in the brain. Dr. Limon’s group uses electrophysiological approaches on reactivated human receptors in the context of transcriptomic, proteomic and clinical information. With this information, it should be possible to advance knowledge of synaptic interactions in health and the rearrangements produced by disease to a point where rational strategies can be developed for effective treatments of brain disorders.

    BioCurriculum Vitae

  • Pappolla, Miguel, MD, PhD

    Miguel A. Pappolla, MD, PhDProfessor

    Dr. Pappolla has extensive research and clinical experience. He holds current board-certifications in 5 areas of medicine, all neuroscience related. His clinical and research expertise contributes with deep understanding of neurodegenerative diseases in their etiology and clinical practice. His lab and collaborative work were among the first to identify evidence of oxidative stress in Alzheimer's disease brain and hypercholesterolemia as an early risk factor for Alzheimer's disease. His work has led to several patents pertaining melatonin analogs as neuroprotective drugs. His clinical interests focus on Neuropathology and Interventional Pain management, and translational research in Alzheimer’s disease.

    BioCurriculum Vitae

  • Sarkar, Partha, PhD

    Partha Sarkar, PhDAssociate Professor

    The Sarkar lab focuses on understanding how microsatellite repeat expansion triggers neurodegeneration in spinocerebellar ataxias, Huntington’s disease (HD) and Parkinson’s disease. The major goal of Dr. Sarkar’s lab is to understand how expanded polyglutamine sequences in the mutant huntingtin protein causes genome instability. His group has discovered that DNA repair is impaired in HD and associated neurodegenerative diseases and is actively trying to understand the contributions of this vital process in many neurodegenerative conditions.

    BioCurriculum Vitae 

  • Wairkar, Yogesh, PhD

    Yogesh Wairkar, PhDAssistant Professor

    Dr. Wairkar’s group is working on the instability of synapses from high expression of MARK4 which makes the synapses vulnerable to tau and Aβ aggregates, which contributes to their eventual loss in AD. Specifically, he is looking to better determine the role of MARK4 in AD to evaluate its importance at early stages of AD. His group uses complementary Drosophila and mouse models, as well as complementary molecular, electrophysiological, and behavioral techniques to answer key questions in neurodegeneration.

    BioCurriculum Vitae 

Admin Staff Mitchell Center

  • Lehrman, Tara

    Tara Lehrman
    Tara Lehrman
    Administrative Assistant